Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature.
Invest New Drugs. 2014 Oct;32(5):1048-52. doi: 10.1007/s10637-014-0063-z. Epub 2014 Jan 18.
Invest New Drugs. 2014.
PMID: 24442368
Review.